Repligen | RGEN - Stammkapital

Aktienkurs
117.60
Täglich Wechseln
3.54 3.10%
Monatlich
2.87%
Jährlich
-18.76%
Q2 Prognose
115.08




Stammkapital Veränderung Datum
Agilent USD 282.7M 358K 2025-12
Align Technology USD 71.75M 736K 2025-12
Bio Techne USD 155.75M 154.18M 2025-09
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Bruker USD 151.94M 225K 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Danaher USD 707.7M 800K 2026-03
Dentsply International USD 199.5M 196.5M 2025-09
General Electric Aerospace USD 1.04B 5.43M 2026-03
Henry Schein USD 115.77M 2.8M 2025-12
Illumina USD 152.8M 900K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Mettler Toledo International USD 20.43M 170.6K 2025-12
Myriad Genetics USD 93.5M 400K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Pfizer USD 5.69B 1000K 2025-09
Repligen USD 56.32M 42K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Standard Biotools USD 386.38M 2.77M 2025-12
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Waters USD 98.08M 38.55M 2025-12
West Pharmaceutical Services USD 70.9M 1.1M 2026-03